Concerning the β1 integrin signaling mediator FAK, recent investigations demonstrated FAK copy number to be associated with disease recurrence in HPV-negative HNSCC [56] and FAK deactivation to elicit radiochemosensitization on HNSCC cells [46,56]. Here, PTK2 is linked to head and neck squamous cell carcinoma.